Path: csiph.com!fu-berlin.de!uni-berlin.de!individual.net!not-for-mail
From: "Carlos E.R." <robin_listas@es.invalid>
Newsgroups: comp.os.linux.misc
Subject: Masks, Covid...
Date: Tue, 16 Sep 2025 21:46:17 +0200
Lines: 17
Message-ID: <9droplx3a.ln2@Telcontar.valinor>
References: <108kv17$73g4$5@dont-email.me> <20250827165330.81eb46a2f8f86d5efb83f0c7@127.0.0.1> <108nnmo$t297$1@dont-email.me> <dr44olxo2p.ln2@Telcontar.valinor> <wp-cne-flI-3ki31nZ2dnZfqnPudnZ2d@giganews.com> <108q123$1g1ph$1@dont-email.me> <mhbkdcFplqiU3@mid.individual.net> <108q9ne$1ieq4$1@dont-email.me> <10a3pjn$egqn$1@dont-email.me> <10a4el4$km8l$2@dont-email.me> <10a5s8v$1360o$5@dont-email.me> <10a60uc$148fh$1@dont-email.me> <10a6r88$1d082$1@dont-email.me> <10a8gq3$261sn$1@news1.tnib.de> <KNCdnQLYl48t61X1nZ2dnZfqnPqdnZ2d@giganews.com> <mis55iFcg7U2@mid.individual.net> <10ab8n3$2fauo$2@dont-email.me> <mitraeF904oU3@mid.individual.net>
Mime-Version: 1.0
Content-Type: text/plain; charset=UTF-8; format=flowed
Content-Transfer-Encoding: 8bit
X-Trace: individual.net HHa2Ke4a7wavtyI8glx1WgVCKSOfWQA8YpkLu1VS5lWXrRgfXs
X-Orig-Path: Telcontar.valinor!not-for-mail
Cancel-Lock: sha1:LZPSG9Zj7CqE+M7ULzzdyPKVmhc= sha256:zGEFceVmteWFPCDdDCnc14b/AEpgibnnfQ2tWn3EALM=
User-Agent: Mozilla Thunderbird
Content-Language: es-ES, en-CA
In-Reply-To: <mitraeF904oU3@mid.individual.net>
Xref: csiph.com comp.os.linux.misc:74342

On 2025-09-16 21:15, rbowman wrote:

...

> Did the pharma companies turn out a profitable product without a lot of
> testing at Warp Speed? At least in the US they might be encouraged by the
> absence of liability if they screw up badly. I forget all the players. Was
> it Johnson & Johnson that had the 'one shot and done' or was J&J the one
> that was pulled due to blood clots?  None of them ever achieved the one
> shot fix. Cynically the need for an annual shot guarantees eternal sales.
> And, no, the shots are not 'free'.

They are here.

-- 
Cheers, Carlos.
ES🇪🇸, EU🇪🇺;